Navigation Links
Stemline Therapeutics Appoints Kevin Buchi, Former CEO of Cephalon, to Its Board of Directors
Date:3/15/2012

NEW YORK, March 15, 2012 /PRNewswire/ -- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk, today announced that Kevin Buchi has joined its Board of Directors.

Since serving as Chief Executive Officer of Cephalon, Inc. through its $6.8 billion acquisition by Teva Pharmaceutical Industries (Nasdaq: TEVA) in October 2011, Mr. Buchi has served as Corporate Vice President, Global Branded Products for Teva. Mr. Buchi joined Cephalon in 1991 and held various positions, including Chief Operating Officer and Chief Financial Officer before becoming Cephalon's CEO in December 2010.

Ivan Bergstein, MD, Stemline's Chief Executive Officer, said, "We are honored to welcome Mr. Buchi to our Board of Directors. Kevin's vast experience and proven track record of success in this industry will be a tremendous asset to Stemline moving forward."

Mr. Buchi commented, "I am delighted to join Stemline's Board of Directors. The management team has done an outstanding job building out a clinical stage pipeline in an innovative area of oncology. I look forward to working with them as they advance these programs into late stage development and potentially into the marketplace."

About Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology therapeutics that target both cancer stem cells (CSCs) as well as the tumor bulk. Among Stemline's drug candidates are SL-401 and SL-701, both of which have demonstrated single agent clinical activity in Phase I/II studies of advanced cancer patients. In a multicenter Phase I/II trial in patients with advanced acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), SL-401 demonstrated single agent activity, including durable c
'/>"/>

SOURCE Stemline Therapeutics, Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center
2. Stemline Therapeutics, Inc. Names Eric K. Rowinsky, M.D. Chief Medical Officer and Head of Research and Development
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zkkg9q/blood_processing ) has announced ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... 2014 through 2020. Also, a seven-year historic analysis is provided ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 Research and ... "Surgical Incision Closures - Global Strategic Business Report" ... comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America ... the worldwide markets for Surgical Incision Closures in US$ Million ...
(Date:6/2/2015)... , June 2, 2015 Intarcia Therapeutics, ... $75 million from its recently announced synthetic royalty / ... $300 million. Investors have purchased Convertible Limited Recourse Notes ... equal to 2.0% of any future global net sales ... fully paid. Investors also have the option, commencing upon ...
Breaking Medicine Technology:Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 3Surgical Incision Closures - Global Strategic Business Report 2015 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3
(Date:6/2/2015)... April 8th, 2015, saw the transformation ... Entertainment’s “RockNRolla Movie Awards” EcoLuxe Lounge, a daylong event, ... of the world’s top providers of ecologically sound and ... by Debbie Durkin, Los Angeles’ leading producer of sustainable ... is a premier red carpet event that makes appearances ...
(Date:6/2/2015)... 2015 On Wednesday, May 27, 2015, professional ... a top speed of 207.9 mph. In the process, ... break the 200 mph mark. Jay Leno was on ... episode of Jay Leno’s Garage, which will air on CNBC ... 8.5 mile high speed oval at the Continental Tire Proving ...
(Date:6/2/2015)... June 02, 2015 Residents looking for ... care in a more convenient location now that Coast ... Village Plaza, 2310 E. Irlo Bronson Memorial Highway, Suite ... less than a mile away from its original location, ... more spacious patient areas with digital intraoral and panoramic ...
(Date:6/2/2015)... June 02, 2015 The 3TVPhoenix contest, conducted ... watch the station’s 6:00 a.m. Good Morning Arizona program for ... the station’s Facebook page. , Lisa Allen of ... She plans to apply the monthly $1,000 prize to ... a stay-at-home mom, expressed her surprise and gratitude at winning, ...
(Date:6/2/2015)... N.Y. (PRWEB) June 02, 2015 The ... to computer generated imagery overlaid on the real world. ... but Vein Visualization, which displays a map of the ... a steady growth in adoption. , AccuVein, the leader ... year over year growth rate and such widespread adoption ...
Breaking Medicine News(10 mins):Health News:Choices Recovery South Bend Discusses Addiction With Rising Hollywood Star Ben Stillwell 2Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:Coast Dental Office Opening In Kissimmee with Expanded Technology 2Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2
... could lessen long-term side effects, study finds , , ... and delaying or avoiding radiation altogether, may be effective ... brain tumors, according to a multi-institutional study. , Low-grade ... If surgery can be performed, the survival rate for ...
... Health (NIH) scientists have identified a protein that plays ... T and B cells, enabling them to interact in ... after an infection. Their finding may also explain ... prevents them from making this proteincalled SAPsuffer from lethal ...
... Oct. 10 Accuray,Incorporated (Nasdaq: ARAY ), a ... it will report results for its first quarter fiscal,year ... 2008 after,the market closes., A conference call to ... p.m. EDT) and will be hosted by Euan S. ...
... Leading Melanoma Specialists Will Give Accredited Course for,Non-Dermatologists ... be held November 1, 2008 at the Royal ... 9 The Melanoma,Foundation of New England and ... Accreditation Council for Continuing Medical Education,(ACCME) course to ...
... a thorough review of multiple,competitive bids, the Virginia ... selected Policy Studies Inc. (PSI) to operate its,full-service ... districts.,PSI is a leading provider of health and ... at approximately $7 million annually and,will run through ...
... HILL The North Carolina Institute for Public Health has ... new research center focused on helping protect the state from ... part of the University of North Carolina at Chapel Hill ... Centers for Disease Control and Prevention (CDC) to head up ...
Cached Medicine News:Health News:Chemo Alone Effective in Treating Kids' Brain Tumors 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2Health News:Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late 2Health News:PSI Selected to Operate Virginia's Child Support Program in Chesapeake and Hampton 2Health News:UNC receives $8.5 million for new public health preparedness research center 2
... Wireless, internet-based ... provides compliance and ... complete system. The ... System incorporates communication ...
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
The CPAP TREND 110 delivers performance with quiet operation. Can be used together with the SomnoPlus CPAP Mask and AquaTrend Heated Humidifier....
... The SleepStyle 200 series offers ... integrated CPAP models. The design delivers ... patients. Performance features promote results in ... care. The strongest differentiator in the ...
Medicine Products: